#LegendNews: Today, we are excited to share plans to establish a new, state-of-the-art research and development (R&D) facility in Philadelphia next year. The new 31,000-square-foot site will advance Legend’s portfolio and expand our R&D capabilities as a global #CellTherapy leader. Read more: https://lnkd.in/e_crDVW7
About us
Legend Biotech is a global, commercial-stage biotechnology company developing and manufacturing novel therapies. We explore and apply innovative technologies to deliver cutting-edge options for patients around the world. Our corporate headquarters is located in Somerset, NJ, and our manufacturing footprint includes facilities in the United States, China and the Belgium.
- Website
-
https://legendbiotech.com/
External link for Legend Biotech
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Somerset, New Jersey
- Type
- Public Company
- Specialties
- R&D, Cell Therapy, CAR-T, CAR-T Manufacturing, Biotechnology, and Pharmaceuticals
Locations
Employees at Legend Biotech
-
Steve Gavel
Senior Vice President, Cell Therapy Commercial Development
-
Frederik Buysse
-
Kathy Rosseel
HR Director - International HR Manager - Senior Human Resources Business Partner
-
Senthil Arumugam, MBA
Director of IT - Global Business Technology Solutions | Head of Data & AI and Application Development | Certified Databricks Azure Platform…
Updates
-
Legend Biotech reposted this
I enjoyed an excellent conversation during "The Forward View on Commercial Autologous Cell Therapies" panel at Goldman Sachs Cell Therapy Day today. I was privileged to exchange insights with Bristol Myers Squibb and Kite Pharma colleagues. It's an exciting time in the #celltherapy space!
-
#LegendNews: Today, we are excited to share our overall survival data in a late-breaking oral presentation at the International Myeloma Society (IMS) Annual Meeting. We strive to transform the treatment landscape with a one-time treatment for those battling #MultipleMyeloma. Read more about our latest results: https://bit.ly/4eJgpCR #MultipleMyeloma #IMS24 #CellTherapy #CART
-
Just because summer is over doesn’t mean the fun ends. Last week, we celebrated our LEGENDary team with food trucks at our HQ in Somerset, NJ. Colleagues gathered for a meal and a well-deserved break to kick off the autumn season! #WeAreLegend #CompanyCulture
-
We are headed to Boston this week to participate in the CAR-TCR Summit Series! If you’re attending, catch our Chief Medical Officer, Mythii Koneru, as she will kick off day two of the Clinical Development track, discussing the significance of administering earlier stage treatment at 11:30 a.m. ET and participate in a panel discussion reviewing the clinical safety of cell therapies at 12:25 p.m. ET on September 19. You can also join Steve Gavel, our Senior Vice President of Commercial Development, later that same day, as he will speak about paving a smooth road to commercial approval of accessible therapies during a panel at 5:15 p.m. ET. #CARTCR #CellTherapy
-
We proudly supported the 12th Annual Miracles for Myeloma 5K Run/Walk in Clark, NJ, organized by the International Myeloma Foundation, over the weekend. It was a fantastic day connecting with the #MultipleMyeloma community and supporting our LEGENDs, their families, and friends. Our Senior Vice President of Global Regulatory Affairs, Yuhong Qiu, reaffirmed our commitment to the cause during the opening remarks. We remain inspired by those who share our goal of finding a cure.
-
At Legend Biotech, we understand the severity of blood cancers and how intractable #MultipleMyeloma is. We are honored to support and partner with the Multiple Myeloma Research Foundation - MMRF and the International Myeloma Foundation to raise awareness for research and one day find a cure. #BloodCancerAwarenessMonth
-
Tomorrow in Lisbon, Portugal, our MS&T Process Engineering & Validation Senior Manager, Emilie Kleiren, will participate in the “Revolutionizing Cell Therapy: MSAT Innovations, Insights, and Strategic Decisions for Developers” presentation during Phacilitate’s Advanced Therapies Europe 2024 at 2:00 p.m. #ATE24 #AdvancedTherapies #CellTherapy
-
In an interview with OncLive, Binod Dhakal, M.D., M.S. shares his perspective on the #MultipleMyeloma landscape. Learn why he’s advising community oncologists to utilize earlier interventions with targeted therapies: https://bit.ly/4e8oNLD #CellTherapy
Similar pages
Browse jobs
Stock
LEGN
NASDAQ
20 minutes delay
$49.07
1.28 (2.678%)
- Open
- 48.92
- Low
- 48.3
- High
- 50.83
Data from Refinitiv
See more info on